Empirical Financial Services LLC d.b.a. Empirical Wealth Management Has $533,000 Holdings in Cigna Group $CI

Empirical Financial Services LLC d.b.a. Empirical Wealth Management decreased its position in Cigna Group (NYSE:CI) by 10.5% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,612 shares of the health services provider’s stock after selling 190 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in Cigna Group were worth $533,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CI. Nuveen LLC acquired a new position in Cigna Group during the first quarter valued at $727,905,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares during the period. GQG Partners LLC lifted its position in shares of Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after purchasing an additional 865,092 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Cigna Group by 38.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after purchasing an additional 457,052 shares during the period. Finally, Bank of Nova Scotia grew its position in Cigna Group by 163.2% during the first quarter. Bank of Nova Scotia now owns 333,435 shares of the health services provider’s stock valued at $109,700,000 after purchasing an additional 206,739 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Price Performance

NYSE CI opened at $311.24 on Monday. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $358.88. The stock’s 50-day moving average is $292.41 and its two-hundred day moving average is $309.65. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market cap of $83.08 billion, a P/E ratio of 16.99, a price-to-earnings-growth ratio of 0.91 and a beta of 0.45.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the prior year, the company posted $6.72 EPS. The firm’s revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Thursday, September 4th. Cigna Group’s payout ratio is presently 32.97%.

Insider Activity

In related news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on CI shares. Wall Street Zen downgraded shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday. Truist Financial set a $375.00 price objective on Cigna Group in a report on Tuesday, September 2nd. Guggenheim reissued a “buy” rating and set a $350.00 price objective (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. TD Cowen upgraded Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Finally, Robert W. Baird set a $372.00 price target on Cigna Group in a research note on Thursday, August 14th. Two analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $371.81.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.